GABAergic inhibition is an important regulator of excitability in neuronal networks. In addition, inhibitory synaptic signals contribute crucially to the organization of spatiotemporal patterns of network activity, especially during coherent oscillations. In order to maintain stable network states, the release of GABA by interneurons must be plastic in timing and amount. This homeostatic regulation is achieved by several pre- and postsynaptic mechanisms and is triggered by various activity-dependent local signals such as excitatory input or ambient levels of neurotransmitters. Here, we review findings on the availability of GABA for release at presynaptic terminals of interneurons. Presynaptic GABA content seems to be an important determinant of inhibitory efficacy and can be differentially regulated by changing synthesis, transport, and degradation of GABA or related molecules. We will discuss the functional impact of such regulations on neuronal network patterns and, finally, point towards pharmacological approaches targeting these processes.
1. Introduction
Activity within neuronal networks is contained between the extremes of complete silence and exceeding neuronal discharges. This general statement may seem intuitively right but has severe and nontrivial consequences for the function of neuronal networks. Several theoretical arguments and experimental findings support the notion that specific mechanisms secure a limited mean level of activity. Information content within neuronal networks is maximal under conditions of sparse coding, which means that only a minority of all local neurons is activated above threshold [1]. Furthermore, neurons are severely damaged by both extremes, that is, prolonged inactivity [2–5] or severe hyperactivity during epileptic seizures [6].
Many different mechanisms contribute to regulation of overall neuronal activity, including intrinsic neuronal properties [7, 8] and energy metabolism [9, 10]. At the core of homeostasis, however, is the interplay between synaptic excitation and inhibition (Figure 1). All neuronal circuits of higher animals contain excitatory and inhibitory transmitter systems forming intense feed-forward and feedback connections [11, 12]. The functional architecture of such networks can already explain homeostatic regulation of activity to a certain degree, and excitatory feedback loops tend to build up activity, which is counterbalanced by dampening actions of inhibitory feedback connections. A further element of cortical and subcortical microcircuits is inhibition of inhibitory neurons, resulting in a net excitation of downstream target cells. This mechanism may serve further functions in synchronizing neuronal activity and can be mediated by specialized interneurons [13]. In contrast, interactions between inhibitory neurons may also desynchronize neurons as, for example, Renshaw cells in the spinal cord [14, 15]. This mechanism may serve to reduce fatigue of muscle fibers.
Local inhibitory connections of cortical networks. Note the efferent and afferent connections indicated by arrows. In red, connections indicate glutamatergic excitation and blue connections GABAergic inhibition. Brown soma indicates an excitatory pyramidal cell (P), and blue-grey somata show inhibitory interneurons (INs). The left interneuron is integrated into a feedback inhibition loop, (FB) while the right interneuron shows feed-forward inhibition (FF). Differential targeting by the interneurons to the soma or dendrite points towards possible layer-specific actions of inhibition. Note that GABA released at the right synapse may, eventually, spill over to the neighbouring glutamatergic synapse. The global light blue staining indicates background GABA concentration that mediates tonic inhibition depending on local synaptic activity.
It should be noted that inhibitory neurons are not only important for balancing excitation. In several circuits, inhibitory neurons function as projection cells, rather than interneurons. For example, major projections within the basal ganglia and reticular nucleus of the thalamus and of the cerebellum are formed by GABAergic neurons [16–18]. In such networks, activity-dependent modulation of inhibition may have specific effects beyond balancing excitation, for example, the generation of specific physiological or pathological oscillation pattern [19].
Homeostasis between excitation and inhibition cannot be reduced to a simple rule of network wiring. Recent evidence shows that inhibition has multiple specific functions within neuronal networks, far beyond a simple “break” [20, 21]. Moreover, inhibitory strength is not constant but must adapt to dynamically changing patterns and degrees of network activity. It does therefore not come as a surprise that recent work has elucidated multiple mechanisms of plasticity at inhibitory synapses [4, 22–24]. An important subset of these mechanisms mediates homeostatic plasticity, that is, adaptation of inhibitory efficacy to the overall activity within a local network. Indeed, several lines of evidence suggest that GABAergic efficacy is upregulated in hyperactive networks [25–29] and downregulated under conditions of reduced activity [5, 30, 31].
Such homeostatic reactions can, in principle, be mediated by multiple pre- and postsynaptic mechanisms. A particularly important regulatory system, however, is the concentration of the main mammalian inhibitory transmitter GABA (γ-aminobutyric acid). This paper shall summarize the molecular elements and functional mechanisms involved in regulation of GABA concentration within vesicles, cells, and in the extracellular space. We will quote experimental evidence indicating that GABA is homeostatically regulated during physiological and pathological changes of network activity. Finally, we will consider how molecular determinants of GABA concentration can be targeted by drugs for pharmacological therapy of neurological or psychiatric diseases.
2. Organization of GABAergic Synapses
In the mammalian CNS, inhibition is mediated by the amino acids GABA and glycine. The GABAergic system has been intensely explored during recent years and will therefore be the main focus of this paper. As a starting point, we will briefly summarize the main functional and structural elements of GABAergic synapses.
GABA binds to two different types of receptors-ion channels and metabotropic receptors. GABA-gated ion channels are selectively permeable for chloride and bicarbonate and have reversal potentials close to Cl− equilibrium (ECl). These channels are mostly termed GABAA receptors, but a molecularly and pharmacologically distinguishable subset has also been termed GABAC receptors until recently, as discussed by Olsen and Seighart [32]. In most cases, the increase in chloride (and bicarbonate) conductance resulting from activation of ionotropic GABA receptors causes inhibition of the respective neuron, that is, decreased probability of action potential generation. This is easy to understand in cases where ECl is more negative than the membrane potential, such that opening of GABAA receptors causes hyperpolarisation and enhances the distance between membrane potential and action potential threshold. However, inhibition can also be mediated by more complex biophysical mechanisms, for example, shunting of the local membrane resistance, which can also counteract excitatory inputs. Even depolarizing actions of GABA can, in certain cases, be inhibitory [33–35]. Conversely, excitatory actions of GABA may occur in specific situations, including early developmental stages [36–39] and maladaptive processes, for example, in chronic epilepsy [40, 41]. The occurrence of depolarizing GABA responses under physiological conditions is presently subject to some controversy [39, 42]. GABAB receptors, in contrast, are members of the family of G-protein-coupled proteins [43] and react to GABA binding by dimerisation [44] and activation of downstream signal cascades. These include decreased probability of transmitter release and increase in pre- and postsynaptic K+ conductance [45, 46].
A complete survey of GABAergic mechanisms at the molecular, cellular, and network level is far beyond the scope of this paper. Rather, we will highlight three principles of organization of GABA-mediated inhibition that are particularly important for understanding how GABA regulates network activity. The molecular constituents involved in regulation of inhibitory strength are detailed below.
GABA regulates excitability on different temporal and spatial scales. One important mechanism is tonic inhibition, which results from diffusely distributed GABA within the extracellular space of networks, thereby reducing excitability of all local neurons (Figure 1). Recent evidence has shown that tonic inhibition is of major importance for reducing firing probability of defined types of neurons within cortical networks [24, 47–49]. In some cells, this mechanism accounts for more than 50% of GABA-induced chloride conductance [50]. Background levels of GABA in neuronal tissue have been estimated to reach high-nanomolar to low-micromolar concentrations [51, 52]. In good accordance with this relatively low concentration, extrasynaptic GABA receptors have particularly high agonist affinity [47, 53, 54]. At the other extreme, phasic inhibition is mediated by locally and temporally restricted release of GABA from synaptic terminals. This action causes a short, exponentially rising and falling of the postsynaptic chloride conductance which can last from few to tens of milliseconds [50, 55]. Most GABAergic neurons seem to form such specific synaptic sites for phasic inhibition, but recent evidence indicates that there are also specialized interneurons which release GABA for tonic inhibition [56–60]. Tonic inhibition depends on special GABA receptors, which can be selectively modulated by drugs, for example, neurosteroids. These specific receptor isoforms may be important in the pathophysiology of depression [61] and withdrawal symptoms [62]. Such examples of receptor heterogeneity may well open new therapeutic chances.
GABAergic interneurons are diverse. Work on different networks has revealed an unprecedented multitude of different GABAergic neurons which are classified by their somatic location, dendritic branching, axonal projection, afferent synaptic integration, intrinsic membrane properties, and expression of molecular markers, especially neuromodulatory peptides and calcium-binding proteins. Extensive classification systems have been established for different circuits, for example, for the rodent neocortex [63, 64] and the hippocampus [13, 65]. Moreover, introducing the juxtacellular recording technique has enabled recordings from individual interneurons in behaving animals and subsequent in-depth structural analysis [66]. These data have shown that different types of interneurons are specialized to organize different patterns of network activity [67].
In accordance with the heterogeneity and functional specialization of different cell types, experiments and computer modelling have revealed important functions of “inhibitory” interneurons in networks beyond merely dampening excitation. Interneurons turned out to play a key role in organizing the spatiotemporal activity of local networks, especially during synchronous network oscillations [68–73]. Complementary neuroanatomical work has highlighted the structural basis for this function: interneurons have highly divergent axonal projections, cell type-specific afferent and efferent connectivity, and synchronizing mutual connections. All these properties favour synchronous rhythmic inhibition of large populations of principal cells [13, 69, 71, 74–76]. It should be noted that the connections between excitatory projection cells and inhibitory interneurons provide an automatic homeostatic mechanisms at the network level. Feed forward or feedback inhibition is driven by excitatory inputs or outputs, respectively, from remote or local excitatory neurons. This mechanism does automatically recruit inhibitory neurons in an activity-dependent manner and, hence, balance local activity (Figure 1).
3. Key Molecules for GABAergic Signalling
The molecular organization of synapses is highly complex, and a complete review would be beyond the scope of this paper. We will restrict our remarks to some families of molecules that are crucial for understanding homeostatic regulation of GABA concentration (Figure 2).
Schematic drawing of transmitter release, transport, and synthesis at a GABAergic synaptic terminal. The axonal ending of an inhibitory interneuron (PRE) is drawn on the left, a glial cell (GLIA) on the right. Bottom structure indicates postsynaptic membrane of a target cell (POST), for example, a pyramidal neuron. Transporters are marked by flanking arrows, and synthesizing or degrading enzymes are marked by a centred arrow. Transporters are colour matched to substrates: GABA is shown as blue particles, glutamate in red, and glutamine in green. GS: glutamine synthetase, Mit: mitochondrion, PAG: phosphate-activated glutaminase, SV: synaptic vesicle, and V-ATPase: vacuolar-type H+-ATPase. For other abbreviations, see the main text.
Like many other neurotransmitters, GABA acts on ionotropic as well as metabotropic ion channels. GABAA receptors are pentameric ion channels composed out of a large variety of 19 homologous subunits [32, 77, 78]. Work during the past decades has elucidated numerous functional differences between molecular subtypes of GABAAR, including different expression patterns, differential modulation by benzodiazepines, neurosteroids and Zn2+, different compartmentalization within neurons, and different agonist affinity [32, 54, 79]. The latter properties are of special interest with respect to GABA concentration. GABAARs with low agonist affinity appear to be clustered at postsynaptic sites, whereas receptors with high affinity are mostly found extrasynaptically [47, 48]. The underlying sorting mechanisms are partially known and involve specific subsynaptic sorting signals within the gamma subunit and interactions with postsynaptic scaffolding proteins like gephyrin and collybistin [80–83]. Extrasynaptic receptors, in contrast, are formed by subunits mediating high agonist affinity including α4, α6, and δ subunits [32, 47]. This distinction reflects the different concentrations of GABA at both sites: whereas synaptically released GABA may reach transient concentrations of ~1.5–3 mM [84, 85], extrasynaptic transmitter concentration has been estimated to lie in the low micromolar range of about 0.2–2.5 μM [47, 51, 52, 86]. As mentioned above, these apparently low “background” concentrations of GABA may be very efficient in regulating excitability [47–50]. An additional distinct location of GABAA receptors is the presynaptic terminal itself. GABAergic auto- or heteroreceptors have been described at the axon terminals of various neurons, including spinal cord afferents [87], hippocampal mossy fibres [88], Schaffer collaterals [89], cerebellar interneurons [90], and pituitary terminals [91]. The effects of such receptors are diverse. Depending on the GABA-induced change in membrane potential and local membrane resistance, presynaptic GABAA receptors may increase or decrease transmitter release [92].
GABAB receptors, on the other hand, are G-protein-coupled transmembrane molecules which are activated by low concentrations of GABA and form dimers which then trigger secondary signalling cascades [43–45]. At presynaptic terminals, activation of GABABRs reduces GABA release, forming the typical negative feedback loop of autoreceptor-mediated synaptic gain control. GABAB receptors are also present at glutamatergic terminals, pointing towards regular spillover of GABA from inhibitory to excitatory synapses (Figure 1, [47, 93–95]). Postsynaptically, GABABRs hyperpolarize and inhibit neurons by activating inwardly rectifying KIR channels, giving rise to the “slow” or “late” phase of inhibition that follows fast, GABAAR-mediated effects and lasts several hundred milliseconds [96]. Furthermore, GABAB receptors can also mediate tonic inhibition, exerting negative control on overall network activity [97].
4. GABA Transport and Synthesis
While GABA receptors act as “detectors” of local GABA concentration, the regulation of GABA itself is achieved by several specialized molecular mechanisms mediating transport, sequestration, synthesis, and the degradation of GABA. We will briefly address each class of molecules involved in these processes.
Membrane-bound GABA transporters move GABA across the cell membrane (Figure 2). The direction and efficacy of this Na+-coupled transport results from the driving electrochemical gradient and is directed inwardly in most situations [98, 99]. However, upon strong depolarization or altered ion homeostasis, GABA transporters can also reverse direction. This mechanism leads to nonvesicular release of GABA which may be of special importance in pathophysiological situations [60, 100, 101]. GABA transporters appear in four different isoforms with affinities around 7 μM for rat GAT-1, 8 μM for rat GAT-2, 12 μM for rat GAT-3, and 93 μM for rat BGT-1 [102–106]. Terminology of GABA transporters is not fully compatible between rats and mice [107]. In the following, we use the abbreviations for rat GABA transporters where ratGAT-1 = mouseGAT1; ratGAT-2 = mouse GAT3; ratGAT-3 = mouseGAT4; ratBGT-1 = mouse GAT2. GABA transporters are differentially expressed in the CNS. As a global rule, GAT-1 is the prevailing neuronal isoform in the rodent brain, and GAT-3 is strongly expressed in glial cells [108–110]. Expression of different GAT isoforms is, however, overlapping, so that selective modulation of one isoform will always affect more than one cell type. It might therefore turn out impossible to achieve a strictly selective block of glial or neuronal GABA uptake with conventional pharmacological tools.
An alternative pathway for enriching GABA in presynaptic terminals is transmitter synthesis from glutamate. Similar to GAT-1/3, there are membrane-bound glutamate transporter molecules at presynaptic terminals of inhibitory interneurons, namely EAAC1 (also called EAAT3) [111–113]. Moreover, neurons can synthesize glutamate from glutamine which can also be taken up by specialized transporters (see below) [114, 115]. GABAergic neurons express both mature isoforms of glutamate decarboxylase, GAD65 and GAD67 [116, 117], that convert the excitatory amino acid into GABA. The smaller isoform GAD65 is directly associated to presynaptic vesicles, indicating that glutamate, once present in the presynaptic cytosol, can be rapidly used for vesicular enrichment of GABA. Indeed, there are direct protein interactions between GAD65 and the vesicular GABA transporter VGAT (= VIAAT, vesicular inhibitory amino acid transporter), suggesting that conversion of glutamate into GABA and subsequent vesicular uptake of the transmitter may be strongly coupled processes [118].
More recently, glutamine has gained interest as an alternative source of GABA. The amino acid glutamine has long been known as the immediate precursor for glutamate. In the extracellular space, glutamine may reach concentrations of hundreds of μM [119, 120]. Enrichment of glutamate in excitatory central neurons involves uptake through specific glutamate transporters by glia cells, conversion into glutamine, export via “system N” glutamine transporters, uptake into neurons by “system A” glutamine transporters, and conversion into glutamate [121, 122]. There is increasing evidence for a similar role of this glutamate/glutamine cycle in GABA synthesis. Indeed, inhibitory interneurons in the hippocampus express the system A transporter SNAT1 [115], but not SNAT2 [123]. Recordings of epileptiform activity in rodent brain slices in vitro have revealed functional evidence for boosting of inhibition by glutamine via this mechanism [124–127]. Using high-resolution recordings of miniature IPSCs in conjunction with pharmacological manipulation of glutamine levels and glutamine transport, these studies showed that glutamine can serve as a source for GABA, especially under conditions of increased synaptic activity. More recent evidence from rat hippocampal slices showed that the contribution of glutamine to vesicular GABA content is more pronounced in immature tissue, and that glutamine forms a constitutive source of vesicular GABA in immature hippocampal synapses on CA1 pyramidal cells. At later stages, the functional importance seems to be restricted to periods of enhanced synaptic activity [128]. This loss of function for constitutive GABA release under resting conditions goes along with an age-dependent decline in expression of SNAT1, both absolutely and in relation to the GABA-synthesizing enzyme GAD65.
5. Sequestration and Degradation of GABA
Within presynaptic terminals of GABAergic neurons, GABA is enriched in vesicles by the vesicular inhibitory amino acid transporter (VGAT = VIAAT). This protein is embedded in the vesicular membrane and uses the electrochemical gradient for H+ to shuffle GABA into small synaptic vesicles [129–133]. Additionally, chloride gradients between vesicle lumen and presynaptic cytosol may contribute to the vesicular loading of GABA [129, 131]. Interestingly, VGAT processes both major mammalian inhibitory transmitters, GABA and glycine. This is a prerequisite for the observed GABAergic/glycinergic cotransmission by single vesicles in the spinal cord [134]. Modelling studies and biochemical data suggest that vesicular GABA uptake may achieve an~1000-fold increase of the transmitter in vesicles as compared to the presynaptic cytosol [135]. On the other side, recent evidence suggests that GABAergic synaptic vesicles are leaky, implying generation of a dynamic equilibrium between accumulation and loss of GABA, given that there is enough time to reach such a steady state [132, 136]. Taking this bidirectional transport into account, the “leaky bathtub” model of synaptic vesicles comes to rather low estimates of concentration gradients between cytosol and the inner vesicle space [132, 135, 137].
Finally, GABA and α-ketoglutarate can be transaminated, producing succinic semialdehyde and glutamate. The reaction is catalysed by GABA transaminase (GABA-T) which is present in mitochondria of glial cells and neurons [138–140]. It is estimated that more than 90% of all GABA in the mammalian CNS is degraded in this way and contributes to energy metabolism in the tricarbonic acid cycle.
In summary, there are several different molecular pathways and compartments for enrichment, synthesis, and degradation of GABA (Figure 2). The resulting concentration of GABA in synaptic vesicles and in the extracellular space depends on the equilibrium between these mechanisms. It should be clearly stated that the absolute concentrations of GABA in the presynaptic cytosol, in vesicles, and in the extrasynaptic space are not known. The affinity constants of extrasynaptic GABA receptors may serve as a rough estimate of background concentrations (0.2–2.5 μM) [86]. Direct measurements from rat cerebrospinal fluid yielded similar or slightly higher values which may be lower in humans [141].
The highly dynamic time course of transmitter concentration in the synaptic cleft, on the other hand, has been estimated based on experimental and theoretical work in different types of neurons. Peak concentrations may be as high as 0.3 to 3 mM [85, 142–147]. The cytosolic GABA concentration is most difficult to estimate or measure, especially since most of the neuronal GABA pool is used for energy metabolism rather than for synaptic inhibition.
It should be explicitly stated that none of the above-given numbers has been directly measured. Indeed, our knowledge on local GABA concentrations in different compartments is far from sufficient. This is even more concerning when we take into account the enormous heterogeneity of neurons [20, 63, 65], the different microarchitecture of different local circuits, and activity-dependent changes in GABA release and ionic homeostasis. A major challenge is the lack of quantitative data about key molecules and structures: How many GABA-uptake molecules are present at a given inhibitory synapse? What is their distribution with respect to the site of release? What is the precise extracellular volume at the synaptic cleft? How much GABA does go into glia cells and neurons, respectively? An important example for progress in this quantitative molecular approach to subcellular structure and function is the recent work on the vesicular proteasome by Takamori and colleagues [136].
6. Regulation of (GABA) in Physiology and Pathophysiology
Different lines of evidence support the view that the cellular and molecular mechanisms mentioned above make important contributions to homeostatic synaptic plasticity. This term covers changes of intrinsic and synaptic neuronal properties, which maintain the mean network activity within a determined range [4, 28]. Taking into consideration that network states change rapidly with changes in vigilance and behavioural state [148, 149], this is a nontrivial task. Individual neurons can change their activity at least by a factor of ~6 in different network patterns [150]. Nevertheless, under normal conditions, networks do neither fall into complete silence, nor into pathological hyperactivity.
Inhibition plays a critical role in network homeostasis. Most circuits contain specialized inhibitory cells which are activated by external afferent excitatory inputs (feedforward inhibition) or by collaterals from efferent excitatory axons (feedback inhibition) as illustrated in Figure 1 [11]. These inhibitory control loops ensure that excitatory neurons are inhibited in an activity-dependent manner. It should be noted, however, that inhibitory interneurons are much more than a “brake” or “gain control.” Recent evidence has revealed many other functions for these heterogeneous neurons: they are critical for organizing the complex spatial and temporal patterns of network oscillations [70, 71], selective gating of defined inputs or outputs [20], suppression of background activity [151], and precise timing of action potentials [67]. Corresponding with these specific functions, we are gaining increasing insight into the complexity of GABAergic signalling, diversity of interneurons, and plasticity of inhibitory synapses.
Notwithstanding these recent findings, however, inhibition does still have its traditional function, that is, limitation of neuronal activity. With respect to network homeostasis, this control function must adapt to changing degrees of activity in the local network. Several lines of evidence indicate that modulating GABA content of inhibitory interneurons is a key mechanism in this regulation process. For example, repetitive hyperactivity in the hippocampus of chronically epileptic rats causes upregulation of GADs, the key enzymes for production of GABA [29]. Conversely, the partial deafferentation of somatosensory cortex resulting from partial limb amputations leads to a downregulation of GABA, but not of GADs [30, 152]. These findings indicate that GABA levels are increased or decreased, respectively, in response to increasing or decreasing network activity. The underlying mechanisms are diverse with respect to time course and source of GABA.
Long-term changes in excitability, such as described above, require regulation of protein expression. Multiple studies from excitatory synapses show that changes in synaptic activity do indeed include lasting effects on protein synthesis and synaptic protein content [153, 154]. The underlying mechanisms involve calcium signalling in dendrites and nuclei [30, 155]. Much less is known about similar mechanisms in inhibitory interneurons. It would be of special importance to understand the activity-dependent regulation of key proteins such as GAD, VGAT, and others. Interestingly, BDNF (brain-derived neurotrophic factor) increases expression of GAD, indicating that neurotrophins are involved in inhibitory homeostatic plasticity. This would be well compatible with the general role of these molecules in activity-dependent plasticity [156]. Surprisingly, genes for inhibitory transmission can also be upregulated in excitatory, glutamatergic neurons following periods of enhanced activity. This intriguing finding suggests that excitatory neurons can adopt an active role in synaptic inhibition in certain situations. Such a “dual phenotype” has been clearly demonstrated in dentate granule cells, a major excitatory input cell type in the rodent hippocampus [157–159]. The axons of granule cells, called mossy fibres, form strong glutamatergic synapses on proximal dendrites of CA3 pyramidal cells and do also contact inhibitory interneurons in this region (an example of feedforward inhibition). Upon strong repetitive stimulation or following epileptic seizures, mossy fibres start expressing proteins needed for the production and vesicular storage of GABA. Electrophysiological measurements show that this GABAergic phenotype is indeed functional, giving rise to mixed excitatory and inhibitory potentials in CA3 pyramids. The GABAergic phenotype of mossy fibres seems to be more pronounced in the juvenile brain [157], consistent with the general principle of enhanced plasticity in immature neurons. While the dual phenotype of granule cells may be an extreme example, several observations indicate that similar activity-dependent changes in expression of GABAergic molecules affect the vesicular pool of GABA in typical inhibitory interneurons. For example, expression of VGAT is altered following ischemia or excitotoxic stimulation [160–162]. These changes go along with altered composition of the vesicular proteome, indicative of altered supply or release of GABAergic vesicles [163].
At a shorter time scale, GABA levels might be regulated by activity-dependent uptake of transmitter molecules. Experimental evidence for such changes came from direct injection of glutamate [164] or glutamine [124, 125] into hippocampal slices. Both approaches increased the amplitudes of miniature inhibitory postsynaptic currents (mIPSCs), indicating that the precursors had indeed been used to fuel the vesicular transmitter pool. Consistent with these findings, blocking membrane-bound transporters for glutamine, GABA, or glutamate can reduce the size of IPSCs [128, 162, 165, 166]. The relative contribution of GABA, glutamate, or glutamine uptake to the vesicular GABA pool remains, however, unknown. It can be expected that the contribution of different transmitter transporters differs among neuronal subtypes, brain regions, and developmental stages [128, 167]. However, due to the fast action of uptake molecules, it is well possible that homeostatic adaptations of intravesicular GABA concentration occur at time scales of few seconds. Strong activation of axons in the CA1 area of mouse hippocampal slices results in a rapid increase of mIPSC amplitudes, with onset time below 20 s. This increase is dependent on uptake of glutamate and GABA, indicating that increased extracellular transmitter concentrations in active neuronal networks automatically provide more “fuel” to the pool of releasable GABA, thereby constituting a negative feedback loop [165].
We have already discussed that tonic activation of GABA receptors by ambient transmitter concentrations provides a major mechanism for regulation of excitability [47, 48, 50]. It may, therefore, well be that changes in GABA uptake, production, and release cause altered tonic inhibition, possibly mediated by specialized subtypes of interneurons [56]. Quantitative knowledge about the contribution of these mechanisms is still lacking. It is also unclear how much nonvesicular release of GABA by reverse transport contributes to ambient GABA concentration. Situations of hyperactivity may favour such release mechanisms by sustained depolarization and altered local ion homeostasis [59, 60, 100, 168].
7. Pharmacological Use
Enhancing GABAergic inhibition is useful for the treatment of several pathological situations, including chronic pain, sleep disorders, anxiety, and—most importantly—epilepsy. In accordance with the principles outlined above, several drugs have been developed which alter presynaptic GABA content. One approach is blocking GABA degradation by GABA transaminase (GABA-T), using the suicide inhibitor γ-vinyl-GABA (GVG). Indeed, this drug does increase GABA levels in the brain [169, 170] and has anticonvulsant efficacy [171, 172]. Studies at the single cell level show that GVG increases miniature IPSC amplitude, consistent with a dynamic regulation of vesicular GABA concentration by the equilibrium between synthesis and degradation [173, 174]. Clinical use of GVG is, however, limited due to pathological changes of retinal cells and resulting scotoma [175].
An alternative approach suited to enhance synaptic GABA levels is the redirection of GABA uptake from glia to neurons. In glial cells, most GABA is degraded and fed into energy metabolism [176]. In contrast, neuronal GABA uptake can recycle the amino acid for use as a transmitter. It would therefore be ideal to have glia-specific GABA uptake inhibitors. Unfortunately, the molecular distinction between glial and neuronal GABA uptake is not strict, although there is some bias for GAT-1 in neurons and GAT-3 in glia [108–110].
In summary, there is no doubt that changes in GABA concentration contribute significantly to network homeostasis in health and disease. More quantitative information about sources, compartmentalization, and local concentration of GABA is urgently needed, not at least in order to develop more specific drugs for reconstituting excitation-inhibition balance in pathological situations.
WolfeJ.HouwelingA. R.BrechtM.Sparse and powerful cortical spikes20102033063122-s2.0-7795476101810.1016/j.conb.2010.03.006HartmanK. N.PalS. K.BurroneJ.MurthyV. N.Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons2006956426492-s2.0-3364685096010.1038/nn1677Schonfeld-DadoE.SegalM.Activity-dependent survival of neurons in culture: a model of slow neurodegeneration200911611136313692-s2.0-7044952641610.1007/s00702-009-0256-3MaffeiA.TurrigianoG. G.Multiple modes of network homeostasis in visual cortical layer 2/320082817437743842-s2.0-4374908912610.1523/JNEUROSCI.5298-07.2008KilmanV.Van RossumM. C. W.TurrigianoG. G.Activity deprivation reduces miniature IPSC amplitude by decreasing the number of postsynaptic GABAA receptors clustered at neocortical synapses2002224132813372-s2.0-0037083302Ben-AriY.Cell death and synaptic reorganizations produced by seizures2001423572-s2.0-003485843810.1046/j.1528-1157.2001.042Suppl.3005.xAdelmanJ.P.MaylieJ.SahP.Small-conductance Ca2+-activated K+ channels: form and function201274245269MartyA.The physiological role of calcium-dependent channels198912114204242-s2.0-0024469642CunninghamM. O.PervouchineD. D.RaccaC.KopellN. J.DaviesC. H.JonesR. S. G.TraubR. D.WhittingtonM. A.Neuronal metabolism governs cortical network response state200610314559756012-s2.0-3364576022610.1073/pnas.0600604103HuchzermeyerC.AlbusK.GabrielH. J.OtáhalJ.TaubenbergerN.HeinemannU.KovácsR.KannO.Gamma oscillations and spontaneous network activity in the hippocampus are highly sensitive to decreases in pO2 and concomitant changes in mitochondrial redox state2008285115311622-s2.0-3874908302510.1523/JNEUROSCI.4105-07.2008MohlerH.MalherbeP.DraguhnA.RichardsJ. G.GABAA-receptors: structural requirements and sites of gene expression in mammalian brain19901521992072-s2.0-0025195595FerranteM.MiglioreM.AscoliG. A.Feed-forward inhibition as a buffer of the neuronal input-output relation20091064218004180092-s2.0-7044956430510.1073/pnas.0904784106FreundT. F.BuzsákiG.Interneurons of the Hippocampus1996643474702-s2.0-0030337503MaltenfortM. G.HeckmanC. J.RymerW. Z.Decorrelating actions of renshaw interneurons on the firing of spinal motoneurons within a motor nucleus: a simulation study19988013093232-s2.0-0031869648AlvarezF. J.FyffeR. E. W.The continuing case for the Renshaw cell2007584131452-s2.0-3484892216610.1113/jphysiol.2007.136200TepperJ. M.WilsonC. J.KoósT.Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons20085822722812-s2.0-4964909956210.1016/j.brainresrev.2007.10.008Gonzalo-RuizA.LiebermanA. R.GABAergic projections from the thalamic reticular nucleus to the anteroventral and anterodorsal thalamic nuclei of the rat1995931651742-s2.0-002879178410.1016/0891-0618(95)00078-XFredetteB. J.MugnainiE.The GABAergic cerebello-olivary projection in the rat199118432252432-s2.0-0025767799SchnitzlerA.GrossJ.Normal and pathological oscillatory communication in the brain2005642852962-s2.0-1634438470810.1038/nrn1650KlausbergerT.SomogyiP.Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations2008321588553572-s2.0-4684908326810.1126/science.1149381BirkeG.DraguhnA.No simple brake the complex functions of inhibitory synapses2010431S21S312-s2.0-7795289332110.1055/s-0030-1253376WangL.FontaniniA.MaffeiA.Visual experience modulates spatio-temporal dynamics of circuit activation20115, article 12LamsaK.HeeromaJ. H.KullmannD. M.Hebbian LTP in feed-forward inhibitory interneurons and the temporal fidelity of input discrimination2005879169242-s2.0-2494452334810.1038/nn1486SemyanovA.WalkerM. C.KullmannD. M.GABA uptake regulates cortical excitability via cell type-specific tonic inhibition2003654844902-s2.0-0037408550WierengaC. J.WadmanW. J.Miniature inhibitory postsynaptic currents in CA1 pyramidal neurons after kindling epileptogenesis1999823135213622-s2.0-0032871531TurrigianoG. G.NelsonS. B.Hebb and homeostasis in neuronal plasticity20001033583642-s2.0-003413110110.1016/S0959-4388(00)00091-XTurrigianoG. G.NelsonS. B.Homeostatic plasticity in the developing nervous system200452971072-s2.0-0742323527TurrigianoG. G.Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same19992252212272-s2.0-003313531210.1016/S0166-2236(98)01341-1EsclapezM.HouserC. R.Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy199941234885052-s2.0-003361023010.1002/(SICI)1096-9861(19990927)412:3<488::AID-CNE8>3.0.CO;2-6GarraghtyP. E.LaChicaE. A.KaasJ. H.Injury-induced reorganization of somatosensory cortex is accompanied by reductions in GABA staining1991843473542-s2.0-0026335684HartmanK. N.PalS. K.BurroneJ.MurthyV. N.Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons2006956426492-s2.0-3364685096010.1038/nn1677OlsenR. W.SieghartW.International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update20086032432602-s2.0-5404913768910.1124/pr.108.00505CoombsJ. S.EcclesJ. C.FATTP.The specific ionic conductances and the ionic movements across the motoneuronal membrane that produce the inhibitory post-synaptic potential195513023263742-s2.0-77049235740RudominP.SchmidtR. F.Presynaptic inhibition in the vertebrate spinal cord revisited199912911372-s2.0-003274316310.1007/s002210050933StuartG.Voltage-activated sodium channels amplify inhibition in neocortical pyramidal neurons1999221441502-s2.0-003336197910.1038/5698Ben-AriY.CherubiniE.CorradettiR.GaiarsaJ. L.Giant synaptic potentials in immature rat CA3 hippocampal neurones19894163033252-s2.0-0024430857Ben-AriY.GaiarsaJ. L.TyzioR.KhazipovR.GABA: A pioneer transmitter that excites immature neurons and generates primitive oscillations2007874121512842-s2.0-3574895437010.1152/physrev.00017.2006CherubiniE.GaiarsaJ. L.Ben-AriY.GABA: an excitatory transmitter in early postnatal life199114125155192-s2.0-002594883410.1016/0166-2236(91)90003-DTyzioR.AlleneC.NardouR.PicardoM. A.YamamotoS.SivakumaranS.CaiatiM. D.RheimsS.MinlebaevM.MilhM.FerréP.KhazipovR.RometteJ. L.LorquinJ.CossartR.KhalilovI.NehligA.CherubiniE.Ben-AriY.Depolarizing actions of GABA in immature neurons depend neither on ketone bodies nor on pyruvate201131134452-s2.0-7865089514510.1523/JNEUROSCI.3314-10.2011Ben-AriY.HolmesG. L.Effects of seizures on developmental processes in the immature brain2006512105510632-s2.0-3375068496510.1016/S1474-4422(06)70626-3HuberfeldG.WittnerL.ClemenceauS.BaulacM.KailaK.MilesR.RiveraC.Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy20072737986698732-s2.0-3454861246410.1523/JNEUROSCI.2761-07.2007RheimsS.HolmgrenC. D.ChazalG.MulderJ.HarkanyT.ZilberterT.ZilberterY.GABA action in immature neocortical neurons directly depends on the availability of ketone bodies20091104133013382-s2.0-6765118404310.1111/j.1471-4159.2009.06230.xKaupmannK.HuggelK.HeidJ.FlorP. J.BischoffS.MickelS. J.McMasterG.AngstC.BittigerH.FroestlW.BettlerB.Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors199738666222392462-s2.0-003089468110.1038/386239a0KunerR.KohnG.GrunewaldS.EisenhardtG.BachA.KornauH. C.Role of heteromer formation in GABAB receptor function1999283539874772-s2.0-003292933110.1126/science.283.5398.74BoweryN. G.BrownD. A.The cloning of GABAB receptors199738666222232242-s2.0-003096937810.1038/386223a0MisgeldU.BijakM.JarolimekW.A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system19954644234622-s2.0-002898377510.1016/0301-0082(95)00012-KModyI.Distinguishing between GABAA receptors responsible for tonic and phasic conductances2001268-99079132-s2.0-003476473510.1023/A:1012376215967SemyanovA.WalkerM. C.KullmannD. M.SilverR. A.Tonically active GABAA receptors: modulating gain and maintaining the tone20042752622692-s2.0-194250100610.1016/j.tins.2004.03.005HolterN. I.ZyllaM. M.ZuberN.BruehlC.DraguhnA.Tonic GABAergic control of mouse dentate granule cells during postnatal development2010328130013092-s2.0-7795848968710.1111/j.1460-9568.2010.07331.xBanksM. I.PearceR. A.Kinetic differences between synaptic and extrasynaptic GABAA receptors in CA1 pyramidal cells20002039379482-s2.0-0034143418TossmanU.JonssonG.UngerstedtU.Regional distribution and extracellular levels of amino acids in rat central nervous system198612745335452-s2.0-0022471749LermaJ.HerranzA. S.HerrerasO.In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis198638411451552-s2.0-0022509201HájosN.NusserZ.RanczE. A.FreundT. F.ModyI.Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy20001238108182-s2.0-024247897710.1046/j.1460-9568.2000.00964.xHeversW.LüddensH.The diversity of GABAA receptors: pharmacological and electrophysiological properties of GABAA channel subtypes199818135862-s2.0-0031593981BartosM.VidaI.FrotscherM.GeigerJ. R. P.JonasP.Rapid signaling at inhibitory synapses in a dentate gyrus interneuron network2001218268726982-s2.0-0035871283PriceC. J.CauliB.KovacsE. R.KulikA.LambolezB.ShigemotoR.CapognaM.Neurogliaform neurons form a novel inhibitory network in the hippocampal CA1 area20052529677567862-s2.0-2254444491210.1523/JNEUROSCI.1135-05.2005CapognaM.marco.capogna@pharm.ox.ac.ukNeurogliaform cells and other interneurons of stratum lacunosum-moleculare gate entorhinal-hippocampal dialogue201158981875188310.1113/jphysiol.2010.201004OláhS.FüleM.KomlósiG.VargaC.BáldiR.BarzóP.TamásG.Regulation of cortical microcircuits by unitary GABA-mediated volume transmission20094617268127812812-s2.0-7035068671510.1038/nature08503JonesS. M.PalmerM. J.Activation of the tonic GABAC receptor current in retinal bipolar cell terminals by nonvesicular GABA release200910226916992-s2.0-6814912426910.1152/jn.00285.2009WuY.WangW.Díez-SampedroA.RichersonG. B.Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-120075658518652-s2.0-3654906661510.1016/j.neuron.2007.10.021StröhleA.RomeoE.Di MicheleF.PasiniA.YassouridisA.HolsboerF.RupprechtR.GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment200215911451472-s2.0-003635769910.1176/appi.ajp.159.1.145MaguireJ.ModyI.Steroid hormone fluctuations and GABAAR plasticity2009341S84S902-s2.0-7124911868810.1016/j.psyneuen.2009.06.019AscoliG. A.Alonso-NanclaresL.AndersonS. A.BarrionuevoG.Benavides-PiccioneR.BurkhalterA.BuzsákiG.CauliB.DeFelipeJ.FairénA.FeldmeyerD.FishellG.FregnacY.FreundT. F.GardnerD.GardnerE. P.GoldbergJ. H.HelmstaedterM.HestrinS.KarubeF.KisvárdayZ. F.LambolezB.LewisD. A.MarinO.MarkramH.MũozA.PackerA.PetersenC. C. H.RocklandK. S.RossierJ.RudyB.SomogyiP.StaigerJ. F.TamasG.ThomsonA. M.Toledo-RodriguezM.WangY.WestD. C.YusteR.Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex2008975575682-s2.0-4574911535310.1038/nrn2402MarkramH.Toledo-RodriguezM.WangY.GuptaA.SilberbergG.WuC.Interneurons of the neocortical inhibitory system20045107938072-s2.0-504422249710.1038/nrn1519SomogyiP.KlausbergerT.Defined types of cortical interneurone structure space and spike timing in the hippocampus200556219262-s2.0-1344425435810.1113/jphysiol.2004.078915PinaultD.A novel single-cell staining procedure performed in vivo under electrophysiological control: morpho-functional features of juxtacellularly labeled thalamic cells and other central neurons with biocytin or Neurobiotin19966521131362-s2.0-002986658710.1016/0165-0270(95)00144-1TukkerJ. J.FuentealbaP.HartwichK.SomogyiP.KlausbergerT.Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo20072731818481892-s2.0-3454768764810.1523/JNEUROSCI.1685-07.2007WangX. J.BuzsákiG.Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model19961620640264132-s2.0-0029836487TraubR. D.CunninghamM. O.GloveliT.LeBeauF. E. N.BibbigA.BuhlE. H.WhittingtonM. A.GABA-enhanced collective behavior in neuronal axons underlies persistent gamma-frequency oscillations20031001911047110522-s2.0-014170319810.1073/pnas.1934854100WhittingtonM. A.TraubR. D.KopellN.ErmentroutB.BuhlE. H.Inhibition-based rhythms: experimental and mathematical observations on network dynamics20003833153362-s2.0-003370594810.1016/S0167-8760(00)00173-2MannE. O.PaulsenO.Role of GABAergic inhibition in hippocampal network oscillations20073073433492-s2.0-3425086905610.1016/j.tins.2007.05.003MannE. O.SucklingJ. M.HajosN.GreenfieldS. A.PaulsenO.Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro20054511051172-s2.0-1134425540210.1016/j.neuron.2004.12.016TowersS. K.LeBeauF. E. N.GloveliT.TraubR. D.WhittingtonM. A.BuhlE. H.Fast network oscillations in the rat dentate gyrus in vitro2002872116511682-s2.0-0036089780BlatowM.RozovA.KatonaI.HormuzdiS. G.MeyerA. H.WhittingtonM. A.CaputiA.MonyerH.A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex20033858058172-s2.0-003818251610.1016/S0896-6273(03)00300-3BartosM.VidaI.FrotscherM.MeyerA.MonyerH.GeigerJ. R. P.JonasP.HeidelbergFast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks2002992013222132272-s2.0-003679098310.1073/pnas.192233099CobbS. R.BuhlE. H.HalasyK.PaulsenO.SomogylP.Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons1995378655275782-s2.0-0028846119BarnardE. A.SkolnickP.OlsenR. W.MohlerH.SieghartW.BiggioG.BraestrupC.BatesonA. N.LangerS. Z.International union of pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function19985022913132-s2.0-0031799363MehtaA. K.TickuM. K.An update on GABAA receptors1999292-31962172-s2.0-003293523410.1016/S0165-0173(98)00052-6ModyI.PearceR. A.Diversity of inhibitory neurotransmission through GABAA receptors20042795695752-s2.0-434470781210.1016/j.tins.2004.07.002EssrichC.LorezM.BensonJ. A.FritschyJ. M.LüscherB.Postsynaptic clustering of major GABAA receptor subtypes requires the γ2 subunit and gephyrin1998175635712-s2.0-0032198312KittlerJ. T.McAinshK.MossS. J.Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission2002262-32512682-s2.0-003677157010.1385/MN:26:2-3:251GiustettoM.KirschJ.FritschyJ. M.CantinoD.Sassoè-PognettoM.Localization of the clustering protein gephyrin at GABAergic synapses in the main olfactory bulb of the rat199839522312442-s2.0-003210393310.1002/(SICI)1096-9861(19980601)395:2<231::AID-CNE7>3.0.CO;2-3KneusselM.BetzH.Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model20002394294352-s2.0-003428414810.1016/S0166-2236(00)01627-1MozrzymasJ. W.ZarmowskaE. D.PytelM.MercikK.Modulation of GABAA receptors by hydrogen ions reveals synaptic GABA transient and a crucial role of the desensitization process20032322798179922-s2.0-0041835896BarberisA.PetriniE. M.CherubiniE.Presynaptic source of quantal size variability at GABAergic synapses in rat hippocampal neurons in culture2004207180318102-s2.0-814422211410.1111/j.1460-9568.2004.03624.xGlykysJ.ModyI.The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus20075823116311782-s2.0-3454709725410.1113/jphysiol.2007.134460EcclesJ. C.SchmidtR. F.WillisW. D.Presynaptic inhibition of the spinal monosynaptic reflex pathway19621612822972-s2.0-0011370339AlleH.GeigerJ. R. P.GABAergic spill-over transmission onto hippocampal mossy fiber boutons20072749429502-s2.0-3384662064210.1523/JNEUROSCI.4996-06.2007StasheffS. F.MottD. D.WilsonW. A.Axon terminal hyperexcitability associated with epileptogenesis in vitro. II. Pharmacological regulation by NMDA and GABAA receptors19937039769842-s2.0-0027438656StellB. M.RostaingP.TrillerA.MartyA.Activation of presynaptic GABAA receptors induces glutamate release from parallel fiber synapses20072734902290312-s2.0-3454819010510.1523/JNEUROSCI.1954-07.2007HansenS. L.FjallandB.bf@dfh.dkJacksonM. B.Modulation of GABAA receptors and neuropeptide secretion by the neurosteroid allopregnanolone in posterior and intermediate pituitary2003932919710.1034/j.1600-0773.2003.930206.xDraguhnA.andreas.draguhn@physiologie.uni-heidelberg.deAxmacherN.KolbaevS.Presynaptic ionotropic GABA receptors200744698510.1007/400_2007_040KullmannD. M.Spillover and synaptic cross talk mediated by glutamate and GABA in the mammalian brain20001253393512-s2.0-003458875810.1016/S0079-6123(00)25023-1ScanzianiM.GABA spillover activates postsynaptic GABAB receptors to control rhythmic hippocampal activity20002536736812-s2.0-0033710846VogtK. E.NicollR. A.Glutamate and γ-aminobutyric acid mediate a heterosynaptic depression at mossy fiber synapses in the hippocampus1999963111811222-s2.0-003351444410.1073/pnas.96.3.1118IsaacsonJ. S.SolisJ. M.NicollR. A.Local and diffuse synaptic actions of GABA in the hippocampus19931021651752-s2.0-002740123010.1016/0896-6273(93)90308-EWangY.NeubauerF. B.LüscherH. R.ThurleyK.GABAB receptor-dependent modulation of network activity in the rat prefrontal cortex in vitro2010319158215942-s2.0-7795177533910.1111/j.1460-9568.2010.07191.xCammackJ. N.RakhilinS. V.SchwartzE. A.A GABA transporter operates asymmetrically and with variable stoichiometry19941349499602-s2.0-002802041710.1016/0896-6273(94)90260-7CoreyJ. L.GuastellaJ.DavidsonN.LesterH. A.GABA uptake and release by a mammalian cell line stably expressing a cloned rat brain GABA transporter199411123302-s2.0-0028249043AttwellD.BarbourB.SzatkowskiM.Nonvesicular release of neurotransmitter19931134014072-s2.0-002737676910.1016/0896-6273(93)90145-HDuringM. J.RyderK. M.SpencerD. D.Hippocampal GABA transporter function in temporal-lobe epilepsy199537665361741772-s2.0-0029011707YamauchiA.UchidaS.KwonH. M.PrestonA. S.RobeyR. B.Garcia-PerezA.BurgM. B.HandlerJ. S.Cloning of a Na+- and Cl--dependent betaine transporter that is regulated by hypertonicity199226716496522-s2.0-0026580107GuastellaJ.NelsonN.NelsonH.CzyzykL.KeynanS.MiedelM. C.DavidsonN.LesterH. A.KannerB. I.Cloning and expression of a rat brain GABA transporter19902494974130313062-s2.0-0025048435KannerB. I.BendahanA.Two pharmacologically distinct sodium- and chloride-coupled high-affinity γ-aminobutyric acid transporters are present in plasma membrane vesicles and reconstituted preparations from rat brain1990877255025542-s2.0-0025355478LiuQ. -R.Lopez-CorcueraB.MandiyanS.NelsonH.NelsonN.Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain1993268321062112BordenL. A.SmithK. E.HartigP. R.BranchekT. A.WeinshankR. L.Molecular heterogeneity of the γ-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain19922672921098211042-s2.0-0026757209SchousboeA.WaagepetersenH. S.GABA: homeostatic and pharmacological aspects20071609192-s2.0-3424785896010.1016/S0079-6123(06)60002-2ContiF.f.conti@popcsi.unian.itMeloneM.De BiasiS.MinelliA.BrechaN. C.DucatiA.Neuronal and glial localization of GAT-1, a high-affinity γ-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex19983961516310.1002/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-HMinelliA.DeBiasiS.BrechaN. C.ZuccarelloL. V.ContiF.GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex19961619625562642-s2.0-0029789256RibakC. E.TongW. M. Y.BrechaN. C.GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus199636745956062-s2.0-002988013210.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#RothsteinJ. D.MartinL.LeveyA. I.Dykes-HobergM.JinL.WuD.NashN.KunclR. W.Localization of neuronal and glial glutamate transporters19941337137252-s2.0-002806064810.1016/0896-6273(94)90038-8ContiF.f.conti@popcsi.unian.itDeBiasiS.MinelliA.RothsteinJ. D.MeloneM.EAAC1, a high-affinity glutamate transporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex19988210811610.1093/cercor/8.2.108HeY.JanssenW. G. M.RothsteinJ. D.MorrisonJ. H.Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit GluR2 in the rat hippocampus200041832552692-s2.0-003396149810.1002/(SICI)1096-9861(20000313)418:3<255::AID-CNE2>3.0.CO;2-6LarssonO. M.DrejerJ.KvammeE.SvennebyG.HertzL.SchousboeA.Ontogenetic development of glutamate and GABA metabolizing enzymes in cultured cerebral cortex interneurons and in cerebral cortex in vivo1985321771852-s2.0-0000027898MeloneM.QuaglianoF.BarbaresiP.VaroquiH.EricksonJ. D.ContiF.Localization of the glutamine transporter SNAT1 in rat cerebral cortex and neighboring structures, with a note on its localization in human cortex20041455625742-s2.0-234252203510.1093/cercor/bhh018ErlanderM. G.TobinA. J.The structural and functional heterogeneity of glutamic acid decarboxylase: a review19911632152262-s2.0-0025816520EsclapezM.TillakaratneN. J. K.KaufmanD. L.TobinA. J.HouserC. R.Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms1994143183418552-s2.0-0028324791JinH.WuH.OsterhausG.WeiJ.DavisK.ShaD.FloorE.HsuC. C.KopkeR. D.WuJ. Y.Demonstration of functional coupling between γ-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles20031007429342982-s2.0-003738657710.1073/pnas.0730698100JacobsonI.SandbergM.HambergerA.Mass transfer in brain dialysis devices—a new method for the estimation of extracellular amino acids concentration19851532632682-s2.0-0022404730KanamoriK.kkanamori@hmri.orgRossB. D.Quantitative determination of extracellular glutamine concentration in rat brain, and its elevation in vivo by system A transport inhibitor, α-(methylamino)isobutyrate200490120321010.1111/j.1471-4159.2004.02478.xBakL. K.SchousboeA.WaagepetersenH. S.The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer20069836416532-s2.0-3374589322810.1111/j.1471-4159.2006.03913.xBröerS.BrookesN.Transfer of glutamine between astrocytes and neurons20017737057192-s2.0-003846962810.1046/j.1471-4159.2001.00322.xGonzález-GonzálezI. M.CubelosB.GiménezC.ZafraF.Immunohistochemical localization of the amino acid transporter SNAT2 in the rat brain2005130161732-s2.0-924422761810.1016/j.neuroscience.2004.09.023LiangS. L.CarlsonG. C.CoulterD. A.Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA120062633853785482-s2.0-3374820362610.1523/JNEUROSCI.0329-06.2006FrickeM. N.Jones-DavisD. M.MathewsG. C.Glutamine uptake by System A transporters maintains neurotransmitter GABA synthesis and inhibitory synaptic transmission20071026189519042-s2.0-3454822535210.1111/j.1471-4159.2007.04649.xBryantA. S.LiB.BeenhakkerM. P.HuguenardJ. R.Maintenance of thalamic epileptiform activity depends on the astrocytic glutamate-glutamine cycle20091025288028882-s2.0-7044938107710.1152/jn.00476.2009TaniH.BandrowskiA. E.ParadaI.WynnM.HuguenardJ. R.PrinceD. A.ReimerR. J.Modulation of epileptiform activity by glutamine and System A transport in a model of post-traumatic epilepsy20072522302382-s2.0-3384630816310.1016/j.nbd.2006.08.025BrownM. N.MathewsG. C.Activity- and age-dependent modulation of GABAergic neurotransmission by System A-mediated glutamine uptake201011439099202-s2.0-7795431985710.1111/j.1471-4159.2010.06823.xAhnert-HilgerG.JahnR.rjahn@gwdg.deCLC-3 spices up GABAergic synaptic vesicles201114440540710.1038/nn.2786HsuC. C.ThomasC.ChenW.DavisK. M.FoosT.ChenJ. L.WuE.FloorE.SchlossJ. V.WuJ. Y.Role of synaptic vesicle proton gradient and protein phosphorylation on ATP-mediated activation of membrane-associated brain glutamate decarboxylase19992743424366243712-s2.0-003358830210.1074/jbc.274.34.24366RiazanskiV.DeriyL. V.ShevchenkoP. D.LeB.GomezE. A.NelsonD. J.nelson@uchicago.eduPresynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus201114448749410.1038/nn.2775EricksonJ. D.De GoisS.VaroquiH.SchaferM. K. H.WeiheE.Activity-dependent regulation of vesicular glutamate and GABA transporters: a means to scale quantal size2006486-76436492-s2.0-3364586586810.1016/j.neuint.2005.12.029HellJ. W.EdelmannL.HartingerJ.JahnR.Functional reconstitution of the γ-aminobutyric acid transporter from synaptic vesicles using artificial ion gradients1991305111795118002-s2.0-0026344693JonasP.BischofbergerJ.SandkühlerJ.Corelease of two fast neurotransmitters at a central synapse199828153754194242-s2.0-003254091910.1126/science.281.5375.419EdwardsR. H.The neurotransmitter cycle and quantal size20075568358582-s2.0-3454856563010.1016/j.neuron.2007.09.001TakamoriS.HoltM.SteniusK.LemkeE. A.GrønborgM.RiedelD.UrlaubH.SchenckS.BrüggerB.RinglerP.MüllerS. A.RammnerB.GräterF.HubJ. S.De GrootB. L.MieskesG.MoriyamaY.KlingaufJ.GrubmüllerH.HeuserJ.WielandF.JahnR.Molecular anatomy of a trafficking organelle200612748318462-s2.0-3375080503010.1016/j.cell.2006.10.030WilliamsJ.How does a vesicle know it is full?19971856836862-s2.0-003097164210.1016/S0896-6273(00)80308-6JungM. J.LippertB.MetcalfB. W.The effect of 4 amino hex 5 ynoic acid (γ acetylenic GABA, γ ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo1977284717723SchousboeI.BroB.SchousboeA.Intramitochondrial localization of the 4 aminobutyrate 2 oxoglutarate transaminase from ox brain197716223033072-s2.0-0017363065KuglerP.In situ measurements of enzyme activities in the brain19932553293382-s2.0-002729522310.1007/BF00159497EcksteinJ. A.AmmermanG. M.RevelesJ. M.AckermannB. L.Analysis of glutamine, glutamate, pyroglutamate, and GABA in cerebrospinal fluid using ion pairing HPLC with positive electrospray LC/MS/MS200817121901962-s2.0-4344909972610.1016/j.jneumeth.2008.02.019BurgerP. M.MehlE.CameronP. L.MaycoxP. R.BaumertM.LottspeichF.De CamilliP.JahnR.Synaptic vesicles immunoisolated from rat cerebral cortex contain high levels of glutamate1989367157202-s2.0-0024848781BarberisA.PetriniE. M.MozrzymasJ. W.Impact of synaptic neurotransmitter concentration time course on the kinetics and pharmacological modulation of inhibitory synaptic currents20115, article 6MozrzymasJ. W.BarberisA.MichalakK.CherubiniE.Chlorpromazine inhibits miniature GABAergic currents by reducing the binding and by increasing the unbinding rate of GABAA receptors1999197247424882-s2.0-0033118570JonesM. V.WestbrookG. L.Desensitized states prolong GABAA channel responses to brief agonist pulses19951511811912-s2.0-0029112106MaconochieD. J.ZempelJ. M.SteinbachJ. H.How quickly can GABAA receptors open?199412161712-s2.0-0028178794PerraisD.RopertN.Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses19991925785882-s2.0-0033556355BuzsákiG.BuhlD. L.HarrisK. D.CsicsvariJ.CzéhB.MorozovA.Hippocampal network patterns of activity in the mouse200311612012112-s2.0-034666574910.1016/S0306-4522(02)00669-3BergerH.Über das Elektrenkephalogramm des Menschen19298715275702-s2.0-3425054862110.1007/BF01797193CsicsvariJ.HiraseH.CzurkóA.MamiyaA.BuzsákiG.Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving rat19991912742872-s2.0-0032907178BähnerF.WeissE. K.BirkeG.MaierN.SchmitzD.RudolphU.FrotscherM.TraubR. D.BothM.DraguhnA.andreas.draguhn@physiologie.uni-heidelberg.deCellular correlate of assembly formation in oscillating hippocampal networks in vitro201110835E607E61610.1073/pnas.1103546108TremereL. A.PinaudR.Incongruent restoration of inhibitory transmission and general metabolic activity during reorganization of somatosensory cortex20051157100310152-s2.0-2164445403110.1080/00207450590901503Costa-MattioliM.SossinW. S.KlannE.SonenbergN.Translational control of long-lasting synaptic plasticity and memory200961110262-s2.0-5814946909010.1016/j.neuron.2008.10.055LuY.ChristianK.LuB.BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?20088933123232-s2.0-3984908318610.1016/j.nlm.2007.08.018BengtsonC. P.FreitagH. E.WeislogelJ. M.BadingH.Nuclear calcium sensors reveal that repetition of trains of synaptic stimuli boosts nuclear calcium signaling in CA1 pyramidal neurons20109912406640772-s2.0-7865022422810.1016/j.bpj.2010.10.044FradeJ. M.BardeY. A.Nerve growth factor: two receptors, multiple functions19982021371452-s2.0-003200690110.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-QGutiérrezR.The dual glutamatergic-GABAergic phenotype of hippocampal granule cells20052862973032-s2.0-2014436224810.1016/j.tins.2005.04.005Gómez-LiraG.LamasM.Romo-ParraH.GutiérrezR.Programmed and induced phenotype of the hippocampal granule cells20052530693969462-s2.0-2304447174510.1523/JNEUROSCI.1674-05.2005WalkerM. C.RuizA.KullmannD. M.Do mossy fibers release GABA?20024351962022-s2.0-003634064610.1046/j.1528-1157.43.s.5.6.xGomesJ. R.LoboA. C.MeloC. V.InácioA. R.TakanoJ.IwataN.SaidoT. C.De AlmeidaL. P.WielochT.DuarteC. B.cbduarte@ci.uc.ptCleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites201131124622463510.1523/JNEUROSCI.3541-10.2011LamasM.Gómez-LiraG.GutiérrezR.Vesicular GABA transporter mRNA expression in the dentate gyrus and in mossy fiber synaptosomes20019322092142-s2.0-003597562610.1016/S0169-328X(01)00202-9SepkutyJ. P.CohenA. S.EcclesC.RafiqA.BeharK.GanelR.CoulterD. A.RothsteinJ. D.A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy20022215637263792-s2.0-0036703472HinzB.BecherA.MitterD.SchulzeK.HeinemannU.DraguhnA.Ahnert-HilgerG.Activity-dependent changes of the presynaptic synaptophysin-synaptobrevin complex in adult rat brain200180106156192-s2.0-0034762707MathewsG. C.DiamondJ. S.Neuronal glutamate uptake contributes to GABA synthesis and inhibitory synaptic strength2003236204020482-s2.0-0037444545HartmannK.BruehlC.GolovkoT.DraguhnA.Fast homeostatic plasticity of inhibition via activity-dependent vesicular filling2008382-s2.0-5204911691910.1371/journal.pone.0002979e2979KirmseK.DvorzhakA.KirischukS.GrantynR.GABA transporter 1 tunes GABAergic synaptic transmission at output neurons of the mouse neostriatum200858623566556782-s2.0-5704913455510.1113/jphysiol.2008.161943DraguhnA.HeinemannU.Different mechanisms regulate IPSC kinetics in early postnatal and juvenile hippocampal granule cells1996766398339932-s2.0-0030463015KrauseS.SchwarzW.Identification and selective inhibition of the channel mode of the neuronal GABA transporter 12005686172817352-s2.0-2784450656710.1124/mol.105.013870GramL.LarssonO. M.JohnsenA. H.SchousboeA.Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons19882287952-s2.0-0023841024LoscherW.JackelR.MullerF.Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model198916311142-s2.0-0024594555BialerM.JohannessenS. I.KupferbergH. J.LevyR. H.LoiseauP.PeruccaE.Progress report on new antiepileptic drugs: a summary of The Fourth Eilat Conference (EILAT IV)19993411412-s2.0-003306157310.1016/S0920-1211(98)00108-9CramerJ. A.FisherR.Ben-MenachemE.FrenchJ.MattsonR. H.New antiepileptic drugs: comparison of key clinical trials19994055906002-s2.0-0032890949EngelD.PahnerI.SchulzeK.FrahmC.JarryH.Ahnert-HilgerG.DraguhnA.Plasticity of rat central inhibitory synapses through GABA metabolism200153524734822-s2.0-003544965810.1111/j.1469-7793.2001.00473.xAxmacherN.DraguhnA.Inhibition of GABA release by presynaptic ionotropic GABA receptors in hippocampal CA320041523293342-s2.0-154229013410.1097/00001756-200402090-00024ButlerW. H.FordG. P.NewberneJ. W.A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats1987152143148SchousboeA.SvennebyG.HertzL.Uptake and metabolism of glutamate in astrocytes cultured from dissociated mouse brain hemispheres197729699910052-s2.0-0017718021